Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




New Test Assessing PML Risk With Natalizumab Targeted for Early 2011
Link ID 29871
Title New Test Assessing PML Risk With Natalizumab Targeted for Early 2011
Url http://www.medscape.com/viewarticle/730736?src=rss
Description Biogen Idec and Elan Corporation are racing to bring a JC virus assay to market to boost confidence in natalizumab for multiple sclerosis. Medscape Medical News
Category Articles > Internal Medicine
Keywords
Date Oct 19, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Internal Medicine
1. Pneumothorax a Common Complication of Thoracentesis
  More than 5% of thoracentesis procedures lead to pneumothorax, a meta-analysis indicates. Reuters Health Information
Category:   Articles > Internal Medicine


2. Combination Therapy With Antibiotics Shows Promise in Severe MS
  The addition of doxycycline -- an inexpensive and safe antibiotic -- to standard therapy with interferon beta-1a is showing promise in patients with relapsing remitting multiple sclerosis. Medscape Medical News
Category:   Articles > Internal Medicine


3. Higher Heart Risk Seen in Younger African Americans
  African Americans are known to have a higher rate of heart disease and stroke than whites, and a new study suggests that those excess risks emerge at a relatively young age. Reuters Health Information
Category:   Articles > Internal Medicine


4. The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake
  This American Headache Society Position Paper reviews the available evidence of the potential risk of combining triptans with other serotonergic agents. Headache
Category:   Articles > Internal Medicine


5. Educated People Cope Better With Dementia
  Educated people are better able to cope with the physical effects of dementia, and even one extra year of education can significantly cut the risk of developing the brain-wasting disease, a study shows. Reuters Health Information
Category:   Articles > Internal Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS